Congress Asset Management CO Janux Therapeutics, Inc. Transaction History
Congress Asset Management CO
- $14.4 Billion
- Q3 2025
A detailed history of Congress Asset Management CO transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 55,773 shares of JANX stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
55,773Holding current value
$1.53 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding JANX
# of Institutions
187Shares Held
56MCall Options Held
869KPut Options Held
652K-
Ra Capital Management, L.P. Boston, MA11.2MShares$306 Million5.65% of portfolio
-
Janus Henderson Group PLC London, X04.46MShares$122 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.92MShares$79.9 Million3.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$69.1 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$64.2 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.14B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...